Sherie Masse

478 citations

16 papers · 355 indexed · h-index 12

Co-authors: Akhteruzzaman Molla Dale J. Kempf Clarence J. Maring Hongmei Mo Gennadiy Koev Kent D. Stewart Tatyana Dekhtyar Liangjun Lu
Topics: HIV/AIDS drug development and treatment (14 papers)Hepatitis C virus research (10 papers)HIV Research and Treatment (4 papers)
Cited by: Hepatology Virology Infectious Diseases
Journals: Genetics Journal of Medicinal Chemistry Antimicrobial Agents and Chemotherapy
Partner nations: United States United Kingdom France

In The Last Decade

Sherie Masse

16 papers receiving 332 citations

Peers

Countries citing papers authored by Sherie Masse

Since Specialization

Citations

This map shows the geographic impact of Sherie Masse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sherie Masse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sherie Masse more than expected).

Fields of papers citing papers by Sherie Masse

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sherie Masse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sherie Masse. The network helps show where Sherie Masse may publish in the future.

Co-authorship network of co-authors of Sherie Masse

This figure shows the co-authorship network connecting the top 25 collaborators of Sherie Masse. A scholar is included among the top collaborators of Sherie Masse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sherie Masse. Sherie Masse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Hepatitis C NS5B polymerase inhibitors: Functional equivalents for the benzothiadiazine moiety 2011 ·Bioorganic & Medicinal Chemistry Letters ·Douglas K. Hutchinson,Charles A. Flentge,(unknown),Rolf Wagner,Clarence J. Maring,Warren M. Kati,Yaya Liu,Sherie Masse,Tim Middleton,Hongmei Mo,Debra Montgomery,(unknown),Gennadiy Koev,David W. A. Beno,Kent D. Stewart,Vincent S. Stoll,Akhteruzzaman Molla,Dale J. Kempf	7
2	Synthesis and Biological Characterization of B-Ring Amino Analogues of Potent Benzothiadiazine Hepatitis C Virus Polymerase Inhibitors 2009 ·Journal of Medicinal Chemistry ·John T. Randolph,Charles A. Flentge,Peggy Huang,Douglas K. Hutchinson,Larry L. Klein,Hock Ben Lim,Rubina Mondal,Thomas Reisch,Debra Montgomery,(unknown),Sherie Masse,Lisa E. Hernandez,Rodger F. Henry,Yaya Liu,Gennadiy Koev,Warren M. Kati,Kent D. Stewart,David W. A. Beno,Akhteruzzaman Molla,Dale J. Kempf	34
3	953 CHARACTERIZATION OF RESISTANCE MUTATIONS SELECTED IN VITRO BY THE NON-NUCLEOSIDE HCV POLYMERASE INHIBITORS ABT-333 AND ABT-072 2009 ·Journal of Hepatology ·(unknown),Rubina Mondal,Jill Beyer,Thomas Reisch,Sherie Masse,Warren M. Kati,David Hutchinson,Charles A. Flentge,John T. Randolph,(unknown),(unknown),Renaud Wagner,Pengke Yan,Tsung‐I Lin,Clarence J. Maring,Akhteruzzaman Molla	8
4	Des-A-ring benzothiadiazines: Inhibitors of HCV genotype 1 NS5B RNA-dependent RNA polymerase 2008 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),(unknown),John K. Pratt,Clarence J. Maring,Warren M. Kati,(unknown),Yaya Liu,Gennadiy Koev,Sherie Masse,Debra Montgomery,Akhter Molla,Dale J. Kempf	16
5	Hepatitis C NS5B polymerase inhibitors: 4,4-Dialkyl-1-hydroxy-3-oxo-3,4-dihydronaphthalene-3-yl benzothiadiazine derivatives 2008 ·Bioorganic & Medicinal Chemistry Letters ·Douglas K. Hutchinson,(unknown),Larry L. Klein,(unknown),Daniel P. Larson,Wenping He,(unknown),Warren M. Kati,William E. Kohlbrenner,Yaya Liu,Sherie Masse,Tim Middleton,Akhteruzzaman Molla,Debra Montgomery,David W. A. Beno,Kent D. Stewart,Vincent S. Stoll,Dale J. Kempf	13
6	Characterization of a Novel Human Immunodeficiency Virus Type 1 Protease Inhibitor, A-790742 2008 ·Antimicrobial Agents and Chemotherapy ·Tatyana Dekhtyar,Teresa I. Ng,Liangjun Lu,Sherie Masse,David A. DeGoey,(unknown),David J. Grampovnik,Larry L. Klein,Dale J. Kempf,Akhteruzzaman Molla	5
7	Synthesis and SAR of novel 1,1-dialkyl-2(1H)-naphthalenones as potent HCV polymerase inhibitors 2007 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Daniel P. Larson,Rolf Wagner,(unknown),Todd W. Rockway,Warren M. Kati,Yaya Liu,Sherie Masse,Tim Middleton,Hongmei Mo,Debra Montgomery,Wen Jiang,Gennadiy Koev,Dale J. Kempf,Akhter Molla	16
8	Identification and characterization of mutations conferring resistance to an HCV RNA-dependent RNA polymerase inhibitor in vitro 2007 ·Antiviral Research ·Liangjun Lu,(unknown),Sherie Masse,Ron Pithawalla,P. Santhana Gopala Krishnan,Wei He,Teresa I. Ng,(unknown),Kent D. Stewart,Daniel P. Larson	29
9	Inhibitors of HCV NS5B polymerase: Synthesis and structure–activity relationships of unsymmetrical 1-hydroxy-4,4-dialkyl-3-oxo-3,4-dihydronaphthalene benzothiadiazine derivatives 2007 ·Bioorganic & Medicinal Chemistry Letters ·A. Chris Krueger,Darold L. Madigan,(unknown),Douglas K. Hutchinson,(unknown),Warren M. Kati,Yaya Liu,Clarence J. Maring,Sherie Masse,Keith F. McDaniel,Tim Middleton,Hongmei Mo,Akhteruzzaman Molla,Debra Montgomery,Teresa I. Ng,Dale J. Kempf	17
10	In Vitro Selection and Characterization of Human Immunodeficiency Virus Type 2 with Decreased Susceptibility to Lopinavir 2007 ·Antimicrobial Agents and Chemotherapy ·Sherie Masse,Xiaozhi Lu,Tatyana Dekhtyar,Liangjun Lu,Gennadiy Koev,Feng Gao,Hongmei Mo,Dale J. Kempf,Barry Bernstein,George J. Hanna,Akhteruzzaman Molla	25
11	[620] CHARACTERIZATION OF PHARMACOKINETIC/PHARMACODYNAMIC PARAMETERS FOR THE NOVEL HCV POLYMERASE INHIBITOR A-848837 2007 ·Journal of Hepatology ·(unknown),Renaud Wagner,(unknown),Dian He,(unknown),(unknown),Sherie Masse,(unknown),Catherine Klein,David W. A. Beno,Lisa E. Hernandez,Preethi Krishnan,Ron Pithawalla,(unknown),Timothy Middleton,Robert E. Lanford,Warren M. Kati,Dale J. Kempf	3
12	Discovery of imidazolidine-2,4-dione-linked HIV protease inhibitors with activity against lopinavir-resistant mutant HIV 2006 ·Bioorganic & Medicinal Chemistry ·(unknown),David A. DeGoey,David J. Grampovnik,(unknown),Larry L. Klein,Tatyana Dekhtyar,Sherie Masse,Kennan C. Marsh,(unknown),Dale J. Kempf	24
13	Inhibitors of HCV NS5B polymerase: Synthesis and structure–activity relationships of N-1-benzyl and N-1-[3-methylbutyl]-4-hydroxy-1,8-naphthyridon-3-yl benzothiadiazine analogs containing substituents on the aromatic ring 2006 ·Bioorganic & Medicinal Chemistry Letters ·Todd W. Rockway,Rong Zhang,Dachun Liu,David A. Betebenner,Keith F. McDaniel,John K. Pratt,David W. A. Beno,Debra Montgomery,(unknown),Sherie Masse,Warren M. Kati,Tim Middleton,Akhteruzzaman Molla,Clarence J. Maring,Dale J. Kempf	22
14	Inhibitors of HCV NS5B polymerase: Synthesis and structure–activity relationships of N-alkyl-4-hydroxyquinolon-3-yl-benzothiadiazine sulfamides 2006 ·Bioorganic & Medicinal Chemistry Letters ·A. Chris Krueger,Darold L. Madigan,Wen Jiang,Warren M. Kati,Dachun Liu,Yaya Liu,Clarence J. Maring,Sherie Masse,Keith F. McDaniel,Tim Middleton,Hongmei Mo,Akhteruzzaman Molla,Debra Montgomery,John K. Pratt,Todd W. Rockway,Rong Zhang,Dale J. Kempf	24
15	Mutations Conferring Resistance to a Hepatitis C Virus (HCV) RNA-Dependent RNA Polymerase Inhibitor Alone or in Combination with an HCV Serine Protease Inhibitor In Vitro 2005 ·Antimicrobial Agents and Chemotherapy ·Hongmei Mo,Liangjun Lu,Edward Tam,Ron Pithawalla,Rubina Mondal,Sherie Masse,Tatyana Dekhtyar,Teresa I. Ng,Gennadiy Koev,Vincent S. Stoll,Kent D. Stewart,John K. Pratt,(unknown),Todd W. Rockway,Clarence J. Maring,Akhteruzzaman Molla	87
16	Yeast Meiotic Mutants Proficient for the Induction of Ectopic Recombination 1998 ·Genetics ·JoAnne Engebrecht,Sherie Masse,Luther Davis,Kristine Rose,(unknown)	25

About Sherie Masse

Sherie Masse is a scholar working on Hepatology, Virology and Infectious Diseases, having authored 16 papers that have together received 355 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (14 papers), Hepatitis C virus research (10 papers) and HIV Research and Treatment (4 papers). The work is most often cited by research in Hepatology (201 citations), Virology (47 citations) and Infectious Diseases (170 citations). Sherie Masse has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Akhteruzzaman Molla, Dale J. Kempf, Clarence J. Maring, Hongmei Mo, Gennadiy Koev, Kent D. Stewart, Tatyana Dekhtyar, Liangjun Lu, Teresa I. Ng and Warren M. Kati. Their work appears in journals such as Genetics, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact